Real-life CD34+CD38- leukemic stem cell (LSC) flow quantification in adult AML at diagnosis independently predicts survival of intensively but not AZA-VEN treated patients: A study of prospective observational ALFA-PPP acute leukemia french associationAdriana Pleșa, Christophe Roumier, Stéphanie Mathis et al.|Blood|2025Cited by 1